{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:01:43Z","timestamp":1793142103162,"version":"4.5.0"},"reference-count":37,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"unspecified","delay-in-days":89,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021592","name":"Ekhagastiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S0033291725000716_sec1\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Findings from contemporary clinical trials suggest that psychedelics are generally safe and may be effective in the treatment of various psychiatric disorders. However, less is known about the risks associated with psychedelic use outside of medically supervised contexts, particularly in populations that are typically excluded from participation in clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0033291725000716_sec2\" sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Using a preregistered longitudinal observational research design with a purposive sample of US residents between 18 and 50 years old (\n                      <jats:italic>N<\/jats:italic>\n                      =21,990), we investigated associations between self-reported naturalistic psychedelic use and psychotic and manic symptoms, with emphasis on those with psychiatric histories of schizophrenia or bipolar I disorder.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0033291725000716_sec3\" sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The follow-up survey was completed by 12,345 participants (56% retention), with 505 participants reporting psychedelic use during the 2-month study period. In covariate-adjusted regression models, psychedelic use during the study period was associated with increases in the severity of psychotic and manic symptoms. However, such increases were only observed for those who reported psychedelic use in an illegal context. While increases in the severity of psychotic symptoms appeared to depend on the frequency of use and the intensity of challenging psychedelic experiences, increases in the severity of manic symptoms appeared to be moderated by a personal history of schizophrenia or bipolar I disorder and the subjective experience of insight during a psychedelic experience.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0033291725000716_sec4\" sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The findings suggest that naturalistic psychedelic use specifically in illegal contexts may lead to increases in the severity of psychotic and manic symptoms. Such increases may depend on the frequency of use, the acute subjective psychedelic experience, and psychiatric history.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/s0033291725000716","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T08:19:02Z","timestamp":1743409142000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":21,"title":["Longitudinal associations of naturalistic psychedelic use with psychotic and manic symptoms"],"prefix":"10.1017","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4197-7566","authenticated-orcid":false,"given":"Otto","family":"Simonsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6888-0126","authenticated-orcid":false,"given":"Simon B.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1583-7319","authenticated-orcid":false,"given":"Walter","family":"Osika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-0666","authenticated-orcid":false,"given":"Cecilia U. D.","family":"Stenfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankalp","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6373-4997","authenticated-orcid":false,"given":"Caroline M.","family":"Swords","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanth","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Hendricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"S0033291725000716_r28","doi-asserted-by":"crossref","first-page":"e243630","DOI":"10.1001\/jamahealthforum.2024.3630","article-title":"Psychedelic and MDMA-related adverse effects\u2013call for action","volume":"5","author":"Simonsson","year":"2024a","journal-title":"JAMA Health Forum"},{"key":"S0033291725000716_r36","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.8.787"},{"key":"S0033291725000716_r30","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291723003082"},{"key":"S0033291725000716_r26","first-page":"1","article-title":"Psychedelic use and psychiatric risks","volume":"326","author":"Simonsson","year":"2023b","journal-title":"Psychopharmacology"},{"key":"S0033291725000716_r9","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1124\/pharmrev.121.000514","article-title":"Self-entropic broadening theory: Toward a new understanding of self and behavior change informed by psychedelics and psychosis","volume":"74","author":"Dourron","year":"2022","journal-title":"Pharmacological Reviews"},{"key":"S0033291725000716_r3","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1176\/appi.ajp.22010073","article-title":"A case of prolonged mania, psychosis, and severe depression after psilocybin use: Implications of increased psychedelic drug availability","volume":"179","author":"Barber","year":"2022","journal-title":"American Journal of Psychiatry"},{"key":"S0033291725000716_r20","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675512"},{"key":"S0033291725000716_r5","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-022-00265-5"},{"key":"S0033291725000716_r31","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198410000-00001"},{"key":"S0033291725000716_r11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0293349"},{"key":"S0033291725000716_r33","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2023.3867"},{"key":"S0033291725000716_r4","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116678781"},{"key":"S0033291725000716_r32","first-page":"1","article-title":"mice: Multivariate imputation by chained equations in R","volume":"45","author":"Van Buuren","year":"2011","journal-title":"Journal of Statistical Software"},{"key":"S0033291725000716_r7","doi-asserted-by":"publisher","DOI":"10.1111\/eip.12245"},{"key":"S0033291725000716_r21","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/63.3.581"},{"key":"S0033291725000716_r24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jamapsychiatry.2022.4101","article-title":"Psychedelic drug legislative reform and legalization in the US","volume":"80","author":"Siegel","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"S0033291725000716_r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadr.2021.100240"},{"key":"S0033291725000716_r1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2023.4685"},{"key":"S0033291725000716_r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115349"},{"key":"S0033291725000716_r16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: Guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"Journal of Psychopharmacology"},{"key":"S0033291725000716_r8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/0269881120967878","article-title":"Development of the psychological insight questionnaire among a sample of people who have consumed psilocybin or LSD","volume":"35","author":"Davis","year":"2021","journal-title":"Journal of Psychopharmacology"},{"key":"S0033291725000716_r35","doi-asserted-by":"publisher","DOI":"10.31234\/osf.io\/txzha"},{"key":"S0033291725000716_r18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.14530"},{"key":"S0033291725000716_r19","doi-asserted-by":"publisher","DOI":"10.1177\/20503245221085222"},{"key":"S0033291725000716_r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2024.01.197"},{"key":"S0033291725000716_r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.05.020"},{"key":"S0033291725000716_r10","doi-asserted-by":"publisher","DOI":"10.1177\/2045125316689030"},{"key":"S0033291725000716_r29","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2024.0047"},{"key":"S0033291725000716_r23","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02743-x"},{"key":"S0033291725000716_r17","doi-asserted-by":"publisher","DOI":"10.1177\/02698811221131997"},{"key":"S0033291725000716_r27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2023.01.073"},{"key":"S0033291725000716_r22","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01721-5"},{"key":"S0033291725000716_r13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206443"},{"key":"S0033291725000716_r34","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01832-z"},{"key":"S0033291725000716_r50","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.2171"},{"key":"S0033291725000716_r2","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0006-3223(96)00548-3","article-title":"The Altman self-rating mania scale","volume":"42","author":"Altman","year":"1997","journal-title":"Biological Psychiatry"},{"key":"S0033291725000716_r14","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675513"}],"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0033291725000716","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T08:19:37Z","timestamp":1743409177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291725000716\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":37,"alternative-id":["S0033291725000716"],"URL":"https:\/\/doi.org\/10.1017\/s0033291725000716","relation":{},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"\u00a9 The Author(s), 2025. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e99"}}